These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15505074)

  • 1. BDNF reduces the retinal toxicity of verteporfin photodynamic therapy.
    Paskowitz DM; Nune G; Yasumura D; Yang H; Bhisitkul RB; Sharma S; Matthes MT; Zarbin MA; Lavail MM; Duncan JL
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4190-6. PubMed ID: 15505074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic factors minimize the retinal toxicity of verteporfin photodynamic therapy.
    Paskowitz DM; Donohue-Rolfe KM; Yang H; Yasumura D; Matthes MT; Hosseini K; Graybeal CM; Nune G; Zarbin MA; Lavail MM; Duncan JL
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):430-7. PubMed ID: 17197564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
    Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
    Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
    Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.
    Reinke MH; Canakis C; Husain D; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Ophthalmology; 1999 Oct; 106(10):1915-23. PubMed ID: 10519585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
    She H; Nakazawa T; Matsubara A; Hisatomi T; Young TA; Michaud N; Connolly E; Hafezi-Moghadam A; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2268-77. PubMed ID: 17460290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
    Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
    Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM; Michels S
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.
    Kim IK; Husain D; Michaud N; Connolly E; Lane AM; Durrani K; Hafezi-Moghadam A; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):357-63. PubMed ID: 16384985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
    Huang Y; Xu G; Peng Y; Lin H; Zheng X; Xie M
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular changes after photodynamic therapy.
    Tzekov R; Lin T; Zhang KM; Jackson B; Oyejide A; Orilla W; Kulkarni AD; Kuppermann BD; Wheeler L; Burke J
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):377-85. PubMed ID: 16384988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
    Odergren A; Ming Y; Kvanta A
    Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course and morphology of vascular effects associated with photodynamic therapy.
    Schmidt-Erfurth U; Niemeyer M; Geitzenauer W; Michels S
    Ophthalmology; 2005 Dec; 112(12):2061-9. PubMed ID: 16325705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of choroidal hypofluorescence following combined verteporfin photodynamic therapy and intravitreal triamcinolone acetonide injection.
    Luttrull JK; Spink CJ
    Retina; 2007; 27(6):688-92. PubMed ID: 17621176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.